Wigzell Hans Lennart Rudolf bought SRPT
March 8, 2024 · Form 4 insider transaction
Wigzell Hans Lennart Rudolf bought 15,000 shares of Sarepta Therapeutics, Inc. at $13.90 per share, a transaction worth $208.5K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 3 days after the transaction.
Direction
Acquired (buy-side)
Shares
15,000
Price
$13.90
Total value
$208.5K
InsiderWigzell Hans Lennart Rudolf
RoleDirector
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateMarch 8, 2024
Filing dateMarch 11, 2024
Shares owned after37,840
OwnershipDirect
10b5-1 planNo
AmendedNo